Follow the LSL Pharma Group Inc. share price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares trade on the CA market, under the supervision of SEDI. Operating in the Health Care sector, LSL Pharma Group Inc. has recorded 10 public disclosures. Market capitalisation: €47.5m. The latest transaction was filed on 6 July 2026 (50 - Grant of options). Among the most active insiders: Allard, Guy Paul. All data is openly available.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
45Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,232 of 29,064 companies
12.0
score / 100
Value
12
Quality
12
FCF yld-18%
Earn yld-7.0%
EV/EBITDA34.5x
ROE-32%
Gross mgn18%
Net mgn-9.8%
Debt/EBITDA16.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.